Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease

NCT07444060 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

CD - Crohn's Disease
Stricture; Bowel
IBD - Inflammatory Bowel Disease

Interventions

DRUG: Guselkumab (GUS)
DRUG: Ustekinumab (UST)

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]